137 related articles for article (PubMed ID: 36868903)
21. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study.
Bhide SA; Davies M; Burke K; McNair HA; Hansen V; Barbachano Y; El-Hariry IA; Newbold K; Harrington KJ; Nutting CM
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1360-8. PubMed ID: 20338474
[TBL] [Abstract][Full Text] [Related]
22. A radiobiological and dosimetrical comparison between simultaneous integrated and sequential boost intensity-modulated arc treatment of locally advanced head-and-neck cancer.
Mandal A; Choudhary S; Mani N; Aggarwal SK
J Cancer Res Ther; 2020; 16(3):508-512. PubMed ID: 32719258
[TBL] [Abstract][Full Text] [Related]
23. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.
Hansen EK; Bucci MK; Quivey JM; Weinberg V; Xia P
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):355-62. PubMed ID: 16256277
[TBL] [Abstract][Full Text] [Related]
24. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
Ho KF; Marchant T; Moore C; Webster G; Rowbottom C; Penington H; Lee L; Yap B; Sykes A; Slevin N
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e375-82. PubMed ID: 22197229
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning.
Chen AM; Daly ME; Cui J; Mathai M; Benedict S; Purdy JA
Head Neck; 2014 Nov; 36(11):1541-6. PubMed ID: 23996502
[TBL] [Abstract][Full Text] [Related]
26. Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma?
Chen C; Lin X; Pan J; Fei Z; Chen L; Bai P
Jpn J Radiol; 2013 Sep; 31(9):593-9. PubMed ID: 23749480
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
28. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric effects of repeat computed tomography scan during radiotherapy planning in esophagus carcinoma.
Khan A; Singh SN; Ali T; Palod S; Ojha R; Mahendran C; Bhandari V
J Cancer Res Ther; 2022 Dec; 18(Supplement):S293-S298. PubMed ID: 36510979
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the effectiveness of novel single-intervention adaptive radiotherapy strategies based on daily dose accumulation.
Ciarmatori A; Maffei N; Mistretta GM; Ceroni P; Bernabei A; Meduri B; D'Angelo E; Bruni A; Giacobazzi P; Lohr F; Guidi G
Med Dosim; 2019 Winter; 44(4):379-384. PubMed ID: 30871864
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Target Volume Location and Its Impact on Delivered Dose Using Cone-Beam Computed Tomography Scans for Patients with Head and Neck Cancer.
Grover D; Laraque M; Debenham B
J Med Imaging Radiat Sci; 2019 Sep; 50(3):387-397. PubMed ID: 31522778
[TBL] [Abstract][Full Text] [Related]
32. Automatic segmentation for adaptive planning in nasopharyngeal carcinoma IMRT: Time, geometrical, and dosimetric analysis.
Fung NTC; Hung WM; Sze CK; Lee MCH; Ng WT
Med Dosim; 2020 Spring; 45(1):60-65. PubMed ID: 31345672
[TBL] [Abstract][Full Text] [Related]
33. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial.
Eekers DBP; Roelofs E; Jelen U; Kirk M; Granzier M; Ammazzalorso F; Ahn PH; Janssens GORJ; Hoebers FJP; Friedmann T; Solberg T; Walsh S; Troost EGC; Kaanders JHAM; Lambin P
Radiother Oncol; 2016 Dec; 121(3):387-394. PubMed ID: 27639891
[TBL] [Abstract][Full Text] [Related]
34. Volumetric and positional changes of planning target volumes and organs at risk using computed tomography imaging during intensity-modulated radiation therapy for head-neck cancer: an "old" adaptive radiation therapy approach.
Reali A; Anglesio SM; Mortellaro G; Allis S; Bartoncini S; Ruo Redda MG; Arcadipane F
Radiol Med; 2014 Sep; 119(9):714-20. PubMed ID: 24510758
[TBL] [Abstract][Full Text] [Related]
35. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
36. Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.
Spencer CR; Gay HA; Haughey BH; Nussenbaum B; Adkins DR; Wildes TM; DeWees TA; Lewis JS; Thorstad WL
Cancer; 2014 Dec; 120(24):3994-4002. PubMed ID: 25143048
[TBL] [Abstract][Full Text] [Related]
37. The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6 mm in head and neck squamous cell carcinoma: Significant acute and late toxicity reduction.
Al-Mamgani A; Kessels R; Janssen T; Navran A; van Beek S; Carbaat C; Schreuder WH; Sonke JJ; Marijnen CAM
Radiother Oncol; 2022 Mar; 168():16-22. PubMed ID: 35065998
[TBL] [Abstract][Full Text] [Related]
38. Image guided high-dose-rate brachytherapy versus volumetric modulated arc therapy for head and neck cancer: A comparative analysis of dosimetry for target volume and organs at risk.
Akiyama H; Pesznyák C; Béla D; Ferenczi Ö; Major T; Polgár C; Takácsi-Nagy Z
Radiol Oncol; 2018 Nov; 52(4):461-467. PubMed ID: 30422804
[TBL] [Abstract][Full Text] [Related]
39. Volumetric and dosimetric comparison of organs at risk between the prone and supine positions in postoperative radiotherapy for prostate cancer.
Sawayanagi S; Yamashita H; Ogita M; Kiritoshi T; Nakamoto T; Abe O; Nakagawa K
Radiat Oncol; 2018 Apr; 13(1):70. PubMed ID: 29665832
[TBL] [Abstract][Full Text] [Related]
40. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V
Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
